Literature DB >> 13368566

Blood-groups in relation to malignant diseases.

J CASE, C RAEBURN, W W WALTHER.   

Abstract

Entities:  

Keywords:  BLOOD GROUPS; NEOPLASMS/blood in

Mesh：

Substances：

Year:  1956        PMID： 13368566     DOI： 10.1016/s0140-6736(56)90324-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  DISTRIBUTION OF ABO AND RHESUS BLOOD GROUPS IN RELATION TO SMOKING HABIT.

Authors:  G J BOURKE; J P O'RIORDAN
Journal:  Br J Prev Soc Med       Date:  1964-04

2.  Blood groups of gastric ulcer and carcinoma.

Authors:  W H BEASLEY
Journal:  Br Med J       Date:  1960-04-16

3.  Blood groups and susceptibility to disease: a review.

Authors:  J A F ROBERTS
Journal:  Br J Prev Soc Med       Date:  1957-07

4.  ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.

Authors:  Harvey A Risch; Lingeng Lu; Jing Wang; Wei Zhang; Quanxing Ni; Yu-Tang Gao; Herbert Yu
Journal:  Am J Epidemiol       Date:  2013-05-06       Impact factor: 4.897

5.  Genetic factors in otosclerosis.

Authors:  A W Morrison
Journal:  Ann R Coll Surg Engl       Date:  1967-08       Impact factor: 1.891

6.  A statistical appraisal on the relationship between non-ABO blood group systems and diseases.

Authors:  M R Chakravartti
Journal:  Humangenetik       Date:  1967-11-29

7.  Gastro-intestinal Cancer and Geochemistry in North Montgomeryshire.

Authors:  I B Millar
Journal:  Br J Cancer       Date:  1961-06       Impact factor: 7.640

8.  THE ABO BLOOD GROUPS OF CARCINOMA OF THE OESOPHAGUS AND OF BENIGN PROSTATIC HYPERPLASIA.

Authors:  W H BEASLEY
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

9.  Ten genetic polymorphisms in bladder cancer.

Authors:  R A Cartwright; R Adib; I Appleyard; J G Coxon; R W Glashan; B Richards; M R Robinson; E Sunderland; D Barham-Hall
Journal:  J Med Genet       Date:  1983-04       Impact factor: 6.318

10.  Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.

Authors:  Jiaqi Huang; Ulrika Zagai; Göran Hallmans; Olof Nyrén; Lars Engstrand; Rachael Stolzenberg-Solomon; Eric J Duell; Kim Overvad; Verena A Katzke; Rudolf Kaaks; Mazda Jenab; Jin Young Park; Raul Murillo; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Kathryn E Bradbury; Elio Riboli; Dagfinn Aune; Konstantinos K Tsilidis; Gabriel Capellá; Antonio Agudo; Vittorio Krogh; Domenico Palli; Salvatore Panico; Elisabete Weiderpass; Anne Tjønneland; Anja Olsen; Begoña Martínez; Daniel Redondo-Sanchez; Maria-Dolores Chirlaque; Petra Hm Peeters; Sara Regnér; Björn Lindkvist; Alessio Naccarati; Eva Ardanaz; Nerea Larrañaga; Marie-Christine Boutron-Ruault; Vinciane Rebours; Amélie Barré; H B As Bueno-de-Mesquita; Weimin Ye
Journal:  Int J Cancer       Date:  2017-04-15       Impact factor: 7.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.